Darbepoetin Alfa
Biologic · tier A · 8 trials (0 recruiting) · 13 publications · score 80.0
Epoetin Alfa
Biologic · tier A · 8 trials (0 recruiting) · 13 publications · score 79.0
Sevelamer Hydrochloride
Drug · tier A · 8 trials (0 recruiting) · 13 publications · score 79.0
Paricalcitol
Drug · tier A · 8 trials (0 recruiting) · 15 publications · score 78.0
Angiotensin Ii
Drug · tier A · 8 trials (0 recruiting) · 12 publications · score 77.0
Valsartan
Drug · tier A · 8 trials (1 recruiting) · 13 publications · score 75.0
Cyclosporine
Drug · tier A · 8 trials (0 recruiting) · 16 publications · score 74.0
Sevelamer Carbonate
Drug · tier A · 8 trials (0 recruiting) · 8 publications · score 70.0
Hydrochlorothiazide
Drug · tier A · 8 trials (3 recruiting) · 7 publications · score 69.0
Telmisartan
Drug · tier A · 8 trials (0 recruiting) · 6 publications · score 63.0
Iron Sucrose
Drug · tier A · 8 trials (1 recruiting) · 6 publications · score 61.0
Perindopril
Drug · tier A · 5 trials (0 recruiting) · 7 publications · score 55.0
Losartan Potassium
Drug · tier A · 8 trials (0 recruiting) · 4 publications · score 49.5
Metoprolol
Drug · tier A · 5 trials (1 recruiting) · 6 publications · score 49.5
Tacrolimus Anhydrous
Drug · tier A · 8 trials (1 recruiting) · 0 publications · score 45.5
Candesartan Cilexetil
Drug · tier A · 8 trials (0 recruiting) · 0 publications · score 45.0
Indomethacin
Drug · tier A · 0 trials (0 recruiting) · 8 publications · score 43.0
Somatropin
Biologic · tier A · 8 trials (1 recruiting) · 0 publications · score 43.0
Eprosartan
Drug · tier A · 1 trials (0 recruiting) · 2 publications · score 27.0
Genistein
Drug · tier A · 0 trials (0 recruiting) · 3 publications · score 27.0
Acetazolamide
Drug · tier A · 0 trials (0 recruiting) · 2 publications · score 24.0
Research map, not treatment advice. Built 2026-10-07.